Katrin Ehrhardt

538 total citations
17 papers, 404 citations indexed

About

Katrin Ehrhardt is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Katrin Ehrhardt has authored 17 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Katrin Ehrhardt's work include Immune Cell Function and Interaction (8 papers), Salmonella and Campylobacter epidemiology (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Katrin Ehrhardt is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Salmonella and Campylobacter epidemiology (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Katrin Ehrhardt collaborates with scholars based in Germany, United States and France. Katrin Ehrhardt's co-authors include Guntram A. Graßl, Hartmut Hengel, Christophe Filippi, Matthias G. von Herrath, Albert Zimmermann, Matthias von Herrath, Yang Cheng, Tobias Boettler, Vu Thuy Khanh Le‐Trilling and Henrike Reinhard and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Virology.

In The Last Decade

Katrin Ehrhardt

17 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrin Ehrhardt Germany 12 213 141 111 63 49 17 404
Jayaum S. Booth United States 12 339 1.6× 135 1.0× 74 0.7× 83 1.3× 34 0.7× 24 563
Christine Rueckert Germany 10 151 0.7× 49 0.3× 145 1.3× 65 1.0× 25 0.5× 12 392
Patrícia de Sousa-Pereira Portugal 7 103 0.5× 32 0.2× 103 0.9× 44 0.7× 57 1.2× 16 330
J H Eldridge United States 11 461 2.2× 86 0.6× 63 0.6× 59 0.9× 84 1.7× 14 627
Lisa N. Henning United States 12 111 0.5× 75 0.5× 193 1.7× 75 1.2× 17 0.3× 23 442
Marcela Simsova Czechia 11 196 0.9× 161 1.1× 78 0.7× 187 3.0× 27 0.6× 11 349
Eiji Watari Japan 14 351 1.6× 161 1.1× 100 0.9× 76 1.2× 39 0.8× 37 554
J O Brubaker United States 7 214 1.0× 133 0.9× 61 0.5× 66 1.0× 11 0.2× 10 360
Naishuo Zhu China 11 101 0.5× 71 0.5× 137 1.2× 44 0.7× 13 0.3× 33 323
Jerry R. McGhee United States 11 252 1.2× 68 0.5× 96 0.9× 37 0.6× 11 0.2× 13 416

Countries citing papers authored by Katrin Ehrhardt

Since Specialization
Citations

This map shows the geographic impact of Katrin Ehrhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin Ehrhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin Ehrhardt more than expected).

Fields of papers citing papers by Katrin Ehrhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrin Ehrhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin Ehrhardt. The network helps show where Katrin Ehrhardt may publish in the future.

Co-authorship network of co-authors of Katrin Ehrhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Katrin Ehrhardt. A scholar is included among the top collaborators of Katrin Ehrhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrin Ehrhardt. Katrin Ehrhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rocha, Cheila, Thomas Neumann, Melanie Galla, et al.. (2024). A tetravalent bispecific antibody outperforms the combination of its parental antibodies and neutralizes diverse SARS-CoV-2 variants. Clinical Immunology. 260. 109902–109902. 1 indexed citations
2.
Suwandi, Abdulhadi, Katrin Ehrhardt, Kumar Nagarathinam, et al.. (2024). Human tetraspanin CD81 facilitates invasion of Salmonella enterica into human epithelial cells. Virulence. 15(1). 2399792–2399792. 2 indexed citations
3.
Ehrhardt, Katrin, et al.. (2023). Determinants of persistent Salmonella infections. Current Opinion in Immunology. 82. 102306–102306. 18 indexed citations
4.
Vallier, Marie, Abdulhadi Suwandi, Katrin Ehrhardt, et al.. (2023). Pathometagenomics reveals susceptibility to intestinal infection by Morganella to be mediated by the blood group-related B4galnt2 gene in wild mice. Gut Microbes. 15(1). 2164448–2164448. 6 indexed citations
5.
Ménard, Sandrine, Sonia Lacroix‐Lamandé, Katrin Ehrhardt, et al.. (2022). Cross-Talk Between the Intestinal Epithelium and Salmonella Typhimurium. Frontiers in Microbiology. 13. 906238–906238. 29 indexed citations
6.
Ehrhardt, Katrin & Guntram A. Graßl. (2022). Mouse Model to Study Salmonella-Induced Colitis. Methods in molecular biology. 2427. 201–213. 9 indexed citations
7.
Ehrhardt, Katrin, Natalie Steck, Reinhild Kappelhoff, et al.. (2019). Persistent Salmonella enterica Serovar Typhimurium Infection Induces Protease Expression During Intestinal Fibrosis. Inflammatory Bowel Diseases. 25(10). 1629–1643. 24 indexed citations
8.
Hoecke, Silvie Van den, Katrin Ehrhardt, Annasaheb Kolpe, et al.. (2017). Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies. Journal of Virology. 91(7). 63 indexed citations
9.
Weber, Arnim, et al.. (2016). Anti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosis. Cell Death and Disease. 7(8). e2340–e2340. 15 indexed citations
10.
Temchura, Vladimir, Franco Pissani, Katrin Ehrhardt, et al.. (2015). Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells. The Journal of Immunology. 195(10). 4861–4872. 31 indexed citations
11.
Honke, Nadine, Namir Shaabani, Katja Merches, et al.. (2015). Immunoactivation induced by chronic viral infection inhibits viral replication and drives immunosuppression through sustained IFN‐I responses. European Journal of Immunology. 46(2). 372–380. 20 indexed citations
12.
Corrales‐Aguilar, Eugenia, Mirko Trilling, Vu Thuy Khanh Le‐Trilling, et al.. (2014). Human Cytomegalovirus Fcγ Binding Proteins gp34 and gp68 Antagonize Fcγ Receptors I, II and III. PLoS Pathogens. 10(5). e1004131–e1004131. 67 indexed citations
14.
Boettler, Tobias, Yang Cheng, Katrin Ehrhardt, & Matthias von Herrath. (2012). TGF-β Blockade Does Not Improve Control of an Established Persistent Viral Infection. Viral Immunology. 25(3). 2014210947–2014210947. 27 indexed citations
15.
Grewe, Bastian, et al.. (2012). The HIV-1 Rev Protein Enhances Encapsidation of Unspliced and Spliced, RRE-Containing Lentiviral Vector RNA. PLoS ONE. 7(11). e48688–e48688. 17 indexed citations
16.
Filippi, Christophe, et al.. (2011). TLR2 signaling improves immunoregulation to prevent type 1 diabetes. European Journal of Immunology. 41(5). 1399–1409. 37 indexed citations
17.
Rottembourg, Diane, et al.. (2010). Essential Role for TLR9 in Prime but Not Prime-Boost Plasmid DNA Vaccination To Activate Dendritic Cells and Protect from Lethal Viral Infection. The Journal of Immunology. 184(12). 7100–7107. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026